SCHEMBL14924316

SCHEMBL14924316

C[N+]1(CCCCCBr)CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.53
KMT2A Q03164 2/20 0.53
APOBEC3A P31941 2/20 0.49
APOBEC3G Q9HC16 2/20 0.49
BBOX1 O75936 2/20 0.45
TSHR P16473 2/20 0.44
CYP3A4 P08684 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
BLM P54132 1/20 0.44
PMP22 Q01453 1/20 0.44
KDM4E B2RXH2 1/20 0.43
CTDSP1 Q9GZU7 2/20 0.40
CHRM2 P08172 1/20 0.38
CHRM4 P08173 1/20 0.38
CHRM5 P08912 1/20 0.38
CHRM1 P11229 1/20 0.38
CHRM3 P20309 1/20 0.38
FOXM1 Q08050 3/20 0.37
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29719599 1.00 LMNA (0.53) LMNAKMT2AAPOBEC3AAPOBEC3GBBOX1
SCHEMBL29112841 1.00 LMNA (0.53) LMNAKMT2AAPOBEC3AAPOBEC3GBBOX1
Bromide SCHEMBL28639847 0.98 LMNA (0.51) LMNAKMT2AAPOBEC3AAPOBEC3GBBOX1
Bromide SCHEMBL14914113 0.98 LMNA (0.51) LMNAKMT2AAPOBEC3AAPOBEC3GBBOX1
SCHEMBL4546781 0.98 LMNA (0.50) LMNAKMT2AAPOBEC3AAPOBEC3GBBOX1
SCHEMBL4546786 0.98 LMNA (0.50) LMNAKMT2AAPOBEC3AAPOBEC3GBBOX1
SCHEMBL14863930 0.98 LMNA (0.50) LMNAKMT2AAPOBEC3AAPOBEC3GBBOX1
Bromide SCHEMBL31452230 0.95 LMNA (0.49) LMNAKMT2AAPOBEC3AAPOBEC3GBBOX1
Bromide SCHEMBL14915227 0.95 LMNA (0.49) LMNAKMT2AAPOBEC3AAPOBEC3GBBOX1
SCHEMBL14734616 0.88 BBOX1 (0.50) LMNAKMT2AAPOBEC3AAPOBEC3GBBOX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240317951-A1 NOVEL POLYFLUORENE-BASED CROSS-LINKED COPOLYMER, METHOD FOR PRODUCING SAME, AND ANION EXCHANGE MEMBRANE FOR ALKALINE FUEL CELL USING SAME IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) (KR) 2024-09-26 US disclosed
CN-116615488-A Novel polyfluorene-based crosslinked copolymer, method for preparing the same, and anion exchange membrane for alkaline fuel cell using the same 汉阳大学校产学协力团 2023-08-18 CN disclosed
WO-2022131665-A1 NOVEL POLYFLUORENE-BASED CROSS-LINKED COPOLYMER, METHOD FOR PRODUCING SAME, AND ANION EXCHANGE MEMBRANE FOR ALKALINE FUEL CELL USING SAME 한양대학교 산학협력단 2022-06-23 WO disclosed
US-9035058-B2 Synthesis of MSE-framework type molecular sieves EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2015-05-19 US disclosed
US-20150087841-A1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2015-03-26 US disclosed
US-8916130-B2 Synthesis of MSE-framework type molecular sieves EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2014-12-23 US disclosed
US-20130115163-A1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150087841-A1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES MRPS2, B2M, UFM1 LMNA 3785/4885KMT2A 489/4885APOBEC3A 4518/4885
US-20130115163-A1 SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES MRPS2, UFM1, B2M LMNA 3760/4885KMT2A 400/4885APOBEC3A 4483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.